# A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)

> **NCT05981274** · — · RECRUITING · sponsor: **Tri-Service General Hospital** · enrollment: 45 (estimated)

## Conditions studied

- Severe Hemophilia A Without Inhibitor

## Interventions

- **DIAGNOSTIC_TEST:** serum biomarker.

## Key facts

- **NCT ID:** NCT05981274
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-14
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2024-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05981274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05981274, "A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT05981274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*